CryoLife provides innovative products that will benefit patients around the world by working with other pioneering companies and by continuous investment in research and development.

The Company's research and development efforts are focused on Protein Hydrogel Technologies, such as BioFoam® Surgical Matrix for parenchymal organ sealing. The Company is also investigating additional applications for its SynerGraft® decellularization technology.

View the video to learn about the SynerGraft Process.